Filing Details
- Accession Number:
- 0001209191-15-076494
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-22 18:51:59
- Reporting Period:
- 2015-10-20
- Filing Date:
- 2015-10-22
- Accepted Time:
- 2015-10-22 18:51:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189184 | Jr F Thomas Kearns | C/O Fibrogen, Inc. 409 Illinois St. San Francsico CA 94158 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-10-20 | 3,100 | $24.17 | 182,436 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-20 | 800 | $24.95 | 181,636 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-21 | 3,400 | $23.26 | 178,236 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-21 | 500 | $23.87 | 177,736 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 110,000 | Indirect | By Trust |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices ranging from $23.71 to $24.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $24.79 to $25.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $22.74 to $23.66. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $23.78 to $24.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
